AstraZeneca makes surprise U-turn with £300m pharma investment

Drugmaker had stalled large-scale UK projects but has now pledged investment at two sites, announced by Keir Starmer

Britain’s biggest drugmaker AstraZeneca has said it will invest £300m in the UK in a surprise U-turn after pausing large-scale projects last year.

The drugmaker had pulled back projects in Britain after becoming disillusioned with the business environment, including the availability of new medicines on the NHS and drug pricing.